Journal Article

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology

Lynam, James, Searles, Andrew, Paul, Christine L., Smith, Stephen, Griffin, Cassandra, Thomas, Ann, Goode, Susan, Fradgley, Elizabeth A., Avery-Kiejda, Kelly A., Greer, Peter, Nielsen, Sarah, Lukeman, Sarah, Martin, Jarad, Zdenkowski, Nick, Ackland, Stephen, Verrills, Nicole M., Scott, Rodney, Weidenhofer, Judith, Ramanathan, Shanthi

2024

Overview

Background Translating research, achieving impact, and assessing impact are important aspirations for all research collaboratives but can prove challenging. The Hunter Cancer Research Alliance (HCRA) was funded from 2014 to 2021 to enhance capacity and productivity in cancer research in a regional centre in Australia. This study aimed to assess the impact and benefit of the HCRA to help inform future research investments of this type. Method The Framework to Assess the Impact from Translational health research (FAIT) was selected as the preferred methodology. FAIT incorporates three validated methodologies for assessing impact: 1) Modified Payback; 2) Economic Analysis; and 3) Narrative overview and case studies. All three FAIT methods are underpinned by a Program Logic Model. Data were collected from HCRA and the University of Newcastle administrative records, directly from HCRA members, and website searches. Results In addition to advancing knowledge and providing capacity building support to members via grants, fellowships, scholarships, training, events and targeted translation support, key impacts of HCRA-member research teams included: (i) the establishment of a regional biobank that has distributed over 13,600 samples and became largely self-sustaining; (ii) conservatively leveraging $43.8 M (s.a.$20.5 M - $160.5 M) in funding and support from the initial $9.7 M investment; (iii) contributing to clinical practice guidelines and securing a patent for identification of stem cells for endometrial cell regeneration; (iv) shifting the treatment paradigm for all tumour types that rely on nerve cell innervation, (v) development and implementation of the world’s first real-time patient treatment verification system (Watchdog); (vi) inventing the effective ‘EAT’ psychological intervention to improve nutrition and outcomes in people experiencing radiotherapy for head and neck cancer; (vi) developing effective interventions to reduce smoking rates among priority groups, currently being rolled out to disadvantaged populations in NSW; and (vii) establishing a Consumer Advisory Panel and Consumer Engagement Committee to increase consumer involvement in research. Conclusion Using FAIT methodology, we have demonstrated the significant impact and downstream benefits that can be achieved by the provision of infrastructure-type funding to regional and rural research collaboratives to help address inequities in research activity and health outcomes and demonstrates a positive return on investment.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Analysis / Cancer patients / Cancer research / Care and treatment / Collaboration / Consumer involvement / Economic analysis / Head & neck cancer / Health Administration / Health Informatics / Health services / Impact assessment / Infrastructure / Integrated delivery networks / Medical research / Medicine / Medicine & Public Health / Nursing Research / Payback method / Public Health / Radiation therapy / Research ethics / Research funding / Researchers / Rural and regional health / Rural areas / Rural health services / Stem cells / Translational research